Researchers using two drugs to fight cancer

Researchers using two drugs to fight cancerCancer researchers have said in a new research that they have used a combination of two drugs to fight the disease more affectively.

They used a combination of two drugs from Bristol-Myers Squibb that was able to reduce the tumors significantly in about 41 per cent of patients with advanced melanoma. The researchers also said that in some of the total 52 patients in the study, the tumors disappeared completely in the patients.

Dr. Jedd D. Wolchok of the Memorial Sloan-Kettering Cancer Center said, "I think it was really the rapidity and the magnitude of the responses that was impressive to us." He was speaking at a press conference organized by the American Society of Clinical Oncology. The society is expected to begin its annual meeting on May 31 in Chicago and the study is expected to a part of the agenda.

Experts say that the Bristol will have a lead following by Merck and Roche are following closely. They said that the drugs are expected to record billions of dollars in annual sales. Roche's drug, which is known as MPDL3280A, showed significant tumor shrinkage in 21 percent of 140 patients.